A significant advance in cancer research is emerging with the use of mini-antibodies to re-engage damaged p53. This essential tumor inhibitor protein is frequently inactivated in several kinds of cancer, resulting https://webcastlist.com/story23468461/nanobodies-restore-p53-the-new-approach-for-malignant-therapy